The benefit of CRT-D versus defibrillator-only therapy in reducing the risk of HF or death was assessed by LAV ( dichotomized at the upper quartile > @ mL/m@ ) among @ patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy ( MADIT-CRT ) study .